Incorporating pharmacokinetic differences between children and adults in assessing children's risks to environmental toxicants
- 19 March 2004
- journal article
- review article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 198 (2) , 164-183
- https://doi.org/10.1016/j.taap.2003.10.010
Abstract
No abstract availableKeywords
This publication has 143 references indexed in Scilit:
- Onset of xenobiotic metabolism in children: Toxicological implicationsFood Additives & Contaminants, 1998
- Toxicokinetics in infants and children in relation to the ADI and TDIFood Additives & Contaminants, 1998
- PHYSIOLOGICAL “CONSTANTS” FOR PBPK MODELS FOR PREGNANCYJournal of Toxicology and Environmental Health, 1997
- Glutathione metabolism in newborns: Evidence for glutathione deficiency in plasma, bronchoalveolar lavage fluid, and lymphocytes in prematuresPediatric Pulmonology, 1995
- Factors affecting species differences in the kinetics of metabolites of trichloroethyleneJournal of Toxicology and Environmental Health, 1995
- Phase I evaluation of zidovudine administered to infants exposed at birth to the human immunodeficiency virusThe Journal of Pediatrics, 1993
- Enhancement of lipid peroxidation in rat liver on acute exposure to styrene and acrylamide a consequence of glutathione depletionChemico-Biological Interactions, 1983
- Barrier properties of the newborn infant's skinPublished by Elsevier ,1983
- Pharmacokinetic profile of caffeine in the premature newborn infant with apneaThe Journal of Pediatrics, 1979
- Glomerular filtration rate, effective renal bloodflow, and maximal tubular excretory capacity in infancyThe Journal of Pediatrics, 1948